Andreas G. Niethammer

Randomized Phase III Trial of Temsirolimus Versus Sorafenib As Second-Line Therapy After Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Thomas E. Hutson, Bernard Escudier, Emilio Esteban et al. · Journal of Clinical Oncology · 2013 · 400 citations · Full text

Medicine, Oncology, Pharmacology +15

A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth

Andreas G. Niethammer, Rong Xiang, Jürgen C. Becker et al. · Nature Medicine · 2002 · 378 citations

Medicine, Immunology, Oncology +17

T cell homeostatic proliferation elicits effective antitumor autoimmunity

Wolfgang Dummer, Andreas G. Niethammer, Roberto Baccalà et al. · Journal of Clinical Investigation · 2002 · 309 citations

Life Sciences, Immunology, Oncology +17

T cell homeostatic proliferation elicits effective antitumor autoimmunity

Wolfgang Dummer, Andreas G. Niethammer, Roberto Baccalà et al. · Journal of Clinical Investigation · 2002 · 265 citations · Full text

Life Sciences, Immunology, Oncology +17

Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial

Brian I. Rini, Joaquim Bellmunt, Jill S. Clancy et al. · Journal of Clinical Oncology · 2013 · 212 citations · Full text

Medicine, Oncology, Pharmacotherapy +14